Uric acid induced hepatocytes lipid accumulation through regulation of miR-149-5p/FGF21 axis
Authors:
Open Access
- 18 February 2020
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 20 (1) , 1-9
Abstract
Background: Hyperuricemia is a major risk for non-alcoholic fatty liver disease. However, the mechanisms for this phenomenon are not fully understood. This study aimed to investigate whether microRNAs mediated the pathogenic effects of uric acid on non-alcoholic fatty liver disease. Methods: Microarray was used to determine the hepatic miRNA expression profiles of male C57BL/6 mice fed on standard chow diet, high fat diet (HFD), and HFD combined with uric acid-lowering therapy by allopurinol. We validated the expression of the most significant differentially expressed microRNAs and explored its role and downstream target in uric acid-induced hepatocytes lipid accumulation. Results: Microarray analysis and subsequent validation showed that miR-149-5p was significantly up-regulated in the livers of HFD-fed mice, while the expression was down-regulated by allopurinol therapy. MiR-149-5p expression was also significantly up-regulated in uric acid-stimulated hepatocytes. Over-expression of miR-149-5p significantly aggregated uric acid-induced triglyceride accumulation in hepatocytes, while inhibiting miR-149-5p ameliorated the triglyceride accumulation. Luciferase report assay confirmed that FGF21 is a target gene of miR-149-5p. Silencing FGF21 abolished the ameliorative effects of miR-149-5p inhibitor on uric acid-induced hepatocytes lipid accumulation, while overexpression of FGF21 prevented the lipid accumulation induced by miR-149-5p mimics. Conclusions: Uric acid significantly up-regulated the expression of miR-149-5p in hepatocytes and induced hepatocytes lipid accumulation via regulation of miR-149-5p/FGF21 axis.Keywords
Funding Information
- National Natural Science Foundation of China (81722009,, 81770573, 81870400)
- Fundamental Research Funds for the Central Universities (2018XZZX002-10, 2019QNA7034)
- Key Research and Development Program of Zhejiang Province (2020C03033)
This publication has 43 references indexed in Scilit:
- Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination SurveyMetabolism, 2013
- MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesisJournal of Clinical Investigation, 2012
- MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanomaProceedings of the National Academy of Sciences, 2011
- Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics, 2011
- Hypouricemic Therapy: A Novel Potential Therapeutic Option for Nonalcoholic Fatty Liver DiseaseHepatology, 2010
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver DiseaseNew England Journal of Medicine, 2010
- High Serum Uric Acid Increases the Risk for Nonalcoholic Fatty Liver Disease: A Prospective Observational StudyPLOS ONE, 2010
- Role of MicroRNA-155 at Early Stages of Hepatocarcinogenesis Induced by Choline-Deficient and Amino Acid–Defined Diet in C57BL/6 Mice†Hepatology, 2009
- Differential expression of microRNAs in mouse liver under aberrant energy metabolic statusJournal of Lipid Research, 2009
- Association of serum uric acid level with non-alcoholic fatty liver disease: A cross-sectional studyJournal of Hepatology, 2009